Corporate Profile
Tarsus is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients with unmet needs. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in its second pivotal Phase 3 trial for the treatment of Demodex blepharitis.
Stock Information
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News
-
May 10, 2022
-
May 06, 2022
-
May 05, 2022
Events
-
May 02, 2022 at 8:00 AM EDT
-
Mar 16, 2022 at 1:50 PM PDT
-
Mar 16, 2022 at 9:40 AM PDT
